What Matters Most in Critical Care—Mortality or ICU Stay? In this clip, Daniella Abi Kheir, PharmD explains the win ratio and why preventing death carries far more weight than simply reducing ICU length of stay. When evaluating treatments, how do we prioritize outcomes? ?? Tune in for this key perspective on patient-centered care! YouTube: https://buff.ly/3QC2Riq Apple Podcast: https://buff.ly/3Uq1Efr Spotify: https://buff.ly/3VyPxhx #PharmSoHard #SGLT2Inhibitors #ICU #CriticalCare #EmergencyMedicine #WinRatio
Pharm So Hard Network
医院和医疗保健
Charleston,South Carolina 545 位关注者
An Emergency Medicine, Hospital Pharmacy, and ambulatory care Podcast network
关于我们
The Pharm So Hard Podcast is a show focused primarily on emergency medicine and hospital pharmacy related topics. Episodes range from 5-30 minutes depending on the topic and guest speakers. The goal is to disseminate information in bite-sized episodes from experts in the field of acute care and hospital pharmacy subspecialties.
- 网站
-
https://pharm-so-hard.com/
Pharm So Hard Network的外部链接
- 所属行业
- 医院和医疗保健
- 规模
- 2-10 人
- 总部
- Charleston,South Carolina
- 类型
- 非营利机构
- 创立
- 2019
地点
Pharm So Hard Network员工
动态
-
Y’all, the FDA just dropped a bomb on the stroke game, and we’re LIVING for it! Tenecteplase is officially a go-go for treating acute ischemic stroke. Let’s be real, we’ve been using it for a while, but now it’s OFFICIAL! ?? Hospitals can switch from alteplase to tenecteplase worry-free. Keep the dose at 0.25mg/kg capping at 25mg because the higher doses are associated with intracranial hemorrhage. Make sure to follow Pharm So Hard podcast as we break keep you updated on the latest in pharmacotherapy ???? #PharmSoHard #StrokeCare #FDAApproved #Tenecteplase #PharmacyLife #PharmD #NewDrugAlert #PharmD
-
?? FDA Update: Tenecteplase (TNKase) is now FDA-approved for acute ischemic stroke in adults! This follows extensive off-label use and strong clinical evidence demonstrating its non-inferiority to alteplase, with the convenience of a quick, single IV bolus administration. An important update to streamline your stroke protocols! #StrokeTreatment #FDAApproval #Tenecteplase #HealthcareUpdate
-
-
Could SGLT2 Inhibitors Protect the Kidneys? In this clip, Daniella Abi Kheir, PharmD explains the theoretical and experimental evidence behind SGLT2 inhibitors in kidney protection. Could these meds actually prevent kidney injury in critically ill patients? ?? Don’t miss this discussion on their potential role in the ICU! YouTube: https://buff.ly/3QC2Riq Apple Podcast: https://buff.ly/3Uq1Efr Spotify: https://buff.ly/3VyPxhx #PharmSoHard #SGLT2Inhibitors #ICU #CriticalCare #Nephrology #EmergencyMedicine
-
Want an Excuse to Go to Vegas? We Know a Guy! If you're into emergency medicine and looking for a next-level conference experience, we’ve got just the thing! The EmpoweRx Conference is happening April 3-6 in Las Vegas, and it’s set to be the #1 event for EM pharmacotherapy. ?? Don’t miss out—mark your calendar and get ready for an unforgettable time! ?? More info: https://buff.ly/3ChgcsA #PharmSoHard #EmpoweRx #EmergencyMedicine #PharmacyConference #VegasBound
-
Why Is Avoiding Dialysis Such a Big Deal? In this clip, Jimmy Pruitt, PharmD, BCPS, BCCCP, BCEMP breaks down why keeping patients off dialysis is a major win in critical care. Once dialysis starts, mortality risk skyrockets—but could SGLT2 inhibitors help prevent that outcome? ?? Listen in to find out why this matters for ICU patients! YouTube: https://buff.ly/3QC2Riq Apple Podcast: https://buff.ly/3Uq1Efr Spotify: https://buff.ly/3VyPxhx #PharmSoHard #SGLT2Inhibitors #ICU #CriticalCare #Nephrology #EmergencyMedicine
-
?? How Do SGLT2 Inhibitors Actually Work? In this clip, Daniella Abi Kheir, PharmD shares why SGLT2 inhibitors are one of her favorite drug classes. Originally designed for diabetes, these meds work by blocking glucose reabsorption in the kidneys—leading to lower blood sugar levels. But is that all they do? ?? Catch the full episode here: YouTube: https://buff.ly/3QC2Riq Apple Podcast: https://buff.ly/3Uq1Efr Spotify: https://buff.ly/3VyPxhx #PharmSoHard #SGLT2Inhibitors #ICU #CriticalCare #EmergencyMedicine #Pharmacy
-
Game-Changer or Missed Opportunity? In this episode, @pharmd_intheed & Daniella Abi Kheir, PharmD, BCPS, BCCCP dive into a hot topic—SGLT2 inhibitors beyond diabetes! ?? Are we overlooking a powerful tool in the ICU? Tune in & find out! ?? Listen now: YouTube: https://buff.ly/3QC2Riq Apple Podcast: https://buff.ly/3Uq1Efr Spotify: https://buff.ly/3VyPxhx #PharmSoHard #ICU #CriticalCarePharmacy #SGLT2 #EmergencyMedicine #GameChanger
-
Bestie, don’t downplay your wins. If you’ve earned it, list it! ??? Scholarships, publications, presentations, awards—they ALL count as achievements! Dr. Alina Luk breaks it down in Ep. 5 of Your PharmD Bestie! ?? Stream this episode on YouTube: https://buff.ly/4hXnvoC Apple Podcast: https://buff.ly/3ZqGKzn #YourPharmDBestie #PhORCAS #PharmacyResidency #FuturePharmD
-
Bestie, your LORs matter! ??? Some programs want letter writers to highlight specific skills—don’t miss out! Dr. Alina Luk shares the inside scoop in Ep. 5 of Your PharmD Bestie. YouTube: https://buff.ly/4hXnvoC Apple Podcast: https://buff.ly/3ZqGKzn #YourPharmDBestie #PhORCAS #PharmacyResidency #LORTips